Notice of Privacy Practices & Confidentiality of Alcohol and Drug Abuse Records
Effective date: 5 September 2015
THIS NOTICE DESCRIBES HOW HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
- CONFIDENTIALITY OF HEALTH INFORMATION. Health information that Narconon Europe receives and/or creates about you, personally, in the program, relating to your past, present, or future health, treatment, or payment for health care services, is “protected health information” under the Federal law known as the Health Insurance Portability and Accountability Act (HIPAA), 45 C.F.R. Parts 160 and 164. The confidentiality of alcohol and drug abuse student records maintained by the program is protected by another Federal law as well, commonly referred to as the Alcohol and Other Drug (AOD) Confidentiality Law, 42 C.F.R. Part 2. Generally, Narconon Europe may not say to a person outside the program that you attend the program, or disclose any information identifying you as an alcohol or drug abuser, or use or disclose any other protected health information except in limited circumstances as permitted by Federal law. Your health information is further protected by any pertinent state law that is more protective or stringent than either of these two Federal laws.
- PLEDGE REGARDING HEALTH INFORMATION. Narconon Europe understands that health information about you and your health is personal. Narconon Europe is committed to protecting health information about you. In order to provide you with quality service and to comply with certain state and federal legal requirements, Narconon Europe creates a record of the services you receive at the Narconon program. This Notice of Privacy Practices & Confidentiality of Alcohol and Drug Abuse Records (the “Notice”) applies to all of the records of your service generated by the Narconon program. This Notice will tell you about the ways in which Narconon Europe may use and disclose protected health information about you. It also describes your rights and certain obligations Narconon Europe has regarding the use and disclosure of protected health information. Narconon Europe is required by law to:
- Make sure that health information that identifies you is kept private;
- Give you this Notice of its legal duties and privacy practices concerning health information about you;
- Follow the terms of the Notice that are currently in effect; and
- Notify you in case there is an unauthorized use or disclosure of your unsecured health information.
- WHO IS BOUND BY THIS NOTICE. This Notice describes Narconon Europe practices and those of Narconon Europe staff, volunteers, and other personnel who are involved in your services. Narconon Europe and these individuals will follow the terms of this Notice, and may use or disclose protected health information about you as permitted or required by law. This Notice describes your rights to access and control protected health information about you, including information that may identify you and that relates to your past, present, or future physical health or mental condition, and health care and related healthcare services. Your personal physician may have other policies that he or she follows and may use his or her own Notice of Privacy Practices.
- HOW NARCONON EUROPE MAY USE AND DISCLOSE PROTECTED HEALTH INFORMATION ABOUT YOU. Narconon Europe collects health information about you and stores it in a chart, on a computer, and in a personal health record. This is your medical record. The medical record is the property of Narconon Europe, but the information in the medical record belongs to you. The following categories describe different ways that Narconon Europe may use or disclose protected health information. For each category of uses and disclosures, Narconon Europe will explain what is meant and may give some examples. Not every use or disclosure in a category will be listed. However, all of the ways Narconon Europe is permitted to use and disclose information will fall within one of the categories. Some information such as certain drug and alcohol information, HIV, or mental health information is entitled to special restrictions.
4.1. For Internal Communications. Your protected health information will be used within the program between and among program staff who have a need for the information, in connection with our duty to diagnose, treat, or refer you for substance abuse treatment. This means that your protected health information may be shared between or among personnel for treatment, payment or health care operation purposes. For example: Two or more providers within the program may consult with each other regarding your best course of treatment. The program may share your protected health information in a billing effort to receive payment for health care services rendered to you. And/or, your protected health information may be discussed within the program about your treatment in connection with others in the program, in an effort to improve the overall quality of care provided by the program. Your protected health information will not be re-disclosed by program personnel except as is otherwise permitted herein.4.2. To Qualified Service Organizations and/or Business Associates. Some or all of your protected health information may be subject to disclosure through contracts for services with qualified service organizations and/or business associates, outside of the program, that assist the program in providing health care. Examples of qualified service organizations and/or business associates include billing companies, data processing companies, or companies that provide administrative or specialty services. To protect your health information, Narconon Europe requires these qualified service organizations and/or business associates to follow the same standards held by the program through terms detailed in a written agreement.4.3. In Medical Emergencies. Your health information may be disclosed to medical personnel in a medical emergency, when there is immediate threat to the health of an individual, and when immediate medical intervention is required.4.4. To Researchers. Under certain circumstances, the program may use and disclose your protected health information for research purposes. For example, a research project may involve comparing the health and recovery of all students who received one test or treatment to those who received another, for the same condition. All research projects, however, must be approved by an Institutional Review Board, or other privacy review board as permitted within the regulations, that has reviewed the research proposal and established protocols to ensure the privacy of your protected health information.4.5. To Auditors and Evaluators. The program may disclose protected health information to regulatory agencies, funders, third-party payers, and peer review organizations that monitor alcohol and drug programs to ensure that the program is complying with regulatory mandates and is properly accounting for and disbursing funds received.4.6. Pursuant to Authorizing Court Order. The program may disclose your protected health information pursuant to an authorizing court order. This is a unique kind of court order in which certain application procedures have been taken to protect your identity, and in which the court makes certain specific determinations as outlined in the Federal regulations and limits the scope of the disclosure.4.7. Crime on Program Premises or Against Program Personnel. The program may disclose a limited amount of protected health information to law enforcement when a student commits or threatens to commit a crime on the program premises or against program personnel. Federal law and regulations do not protect any information about a crime committed by a student either at the program or against any person who works for the program or about any threat to commit such a crime.4.8. Reporting Suspected Child Abuse and Neglect. The program may report suspected child abuse or neglect as mandated by state law. Federal law and regulations do not protect any information about suspected child abuse or neglect from being reported under state law to appropriate state or local authorities.4.9. As Required By Law. The program will disclose protected health information as required by state law in a manner otherwise permitted by federal privacy and confidentiality regulations.4.10. Appointment Reminders. Narconon Europe reserves the right to contact you, in a manner permitted by law, with appointment reminders or information about treatment alternatives and other health related benefits that may be appropriate to you.4.11. Other Uses and Disclosure of Protected Health Information. Other uses and disclosures of protected health information not covered by this Notice will be made only with your written authorization or that of your legal representative. If you or your legal representative authorize Narconon Europe to use or disclose protected health information about you, you or your legal representative may revoke that authorization, at any time, except to the extent that Narconon Europe has already taken action relying on the authorization.
- YOUR RIGHTS REGARDING HEALTH INFORMATION NARCONON EUROPE MAINTAINS ABOUT YOU. You have the following rights regarding your health information. In order to exercise these rights, you must contact the HIPAA Privacy Officer at Narconon Europe. You may be asked to submit a written request. The HIPAA Privacy Officer may be contacted using the following information:
Attn: HIPAA Privacy Officer
Phone: +45 70 60 60 03
Email: [email protected]
5.1. Right to Inspect and Copy. With certain exceptions, you have the right to inspect and receive copies of your health information that Narconon Europe maintains about you. In some very limited circumstances Narconon Europe may, as authorized by law, deny your request to inspect and obtain a copy of your protected health information. You will be notified of a denial to any part or parts of your request. Some denials, by law, are reviewable, and you will be notified regarding the procedures for invoking a right to have a denial reviewed. Other denials, however, as set forth in the law, are not reviewable. Each request will be reviewed individually, and a response will be provided to you in accordance with the law.5.2. Right to Amend Your Health Information. If you believe that protected health information about you is incorrect or incomplete, you may ask Narconon Europe to amend the information. Narconon Europe may deny your request if it is not in writing or does not include a reason that supports the request. In addition, Narconon Europe may deny your request if you ask Narconon Europe to amend protected health information that Narconon Europe believes: (i) is accurate and complete; (ii) was not created by Narconon Europe, unless the person or entity that created the protected health information is no longer available to make the amendment; (iii) is not part of the protected health information kept by or for Narconon Europe; or (iv) is not part of the protected health information which you would be permitted to inspect and copy. If your right to amend is denied, Narconon Europe will notify you of the denial and provide you with instructions on how you may exercise your right to submit a written statement disagreeing with the denial and/or how you may request that your request to amend and a copy of the denial be kept together with the protected health information at issue, and disclosed together with any further disclosures of the protected health information at issue.5.3. Right to an Accounting of Disclosures. You have the right to receive a list of certain disclosures that Narconon Europe may have made of your protected health information. This list will not include certain disclosures as set forth in the HIPAA regulations, including those made for treatment, payment, or health care operations within the program or made pursuant to your authorization or made directly to you.5.4. Right to Request Restrictions. You have the right to request a restriction or limitation on the protected health information that Narconon Europe uses or discloses about your treatment, payment or health care operations within the program. While Narconon Europe will consider your request, Narconon Europe is not required to agree to it. If Narconon Europe does agree to it, Narconon Europe will comply with your request, except in emergency situations where your protected health information is needed to provide you with emergency treatment. Narconon Europe will not agree to restrictions on uses or disclosures that are legally required, or those which are legally permitted and which Narconon Europe reasonably believes to be in the best interest of your health.5.5. Request Confidential Communications. You have the right to request that Narconon Europe communicate with you about your protected health information in a specific way or at a specific location. For example, you can ask that Narconon Europe only contact you at work or by mail. Narconon Europe will accommodate all reasonable requests.5.6. Right to File a Complaint. Violation of the Federal law and regulations by a program is a crime and suspected violations may be reported to appropriate authorities in accordance with Federal regulations. If you have any questions or believe that your privacy rights have been violated, you may contact our HIPAA Privacy Officer in person or mail a written summary of your concern to the address listed above. You may also file a written complaint with the Department of Health and Human Services. You will not be penalized or retaliated against for filing a complaint.5.7. Receive a Copy. You have the right to obtain a copy of this Notice.
- CHANGES TO THIS NOTICE. Narconon Europe reserves the right to change the terms of this Notice at any time. Narconon Europe reserves the right to make the revised or changed notice effective for protected health information the program already has about you as well as any protected health information the program receives in the future. Narconon Europe will post a copy of the current Notice. The Notice will contain an effective date.